Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-25-007012
Filing Date
2025-05-08
Accepted
2025-05-08 17:18:24
Documents
102
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q cyrx-20250331x10q.htm   iXBRL 10-Q 2508620
2 EX-31.1 cyrx-20250331xex31d1.htm EX-31.1 14160
3 EX-31.2 cyrx-20250331xex31d2.htm EX-31.2 13046
4 EX-32.1 cyrx-20250331xex32d1.htm EX-32.1 17143
5 GRAPHIC cyrx-20250331x10q004.jpg GRAPHIC 8177
  Complete submission text file 0001558370-25-007012.txt   12895399

Data Files

Seq Description Document Type Size
6 EX-101.SCH cyrx-20250331.xsd EX-101.SCH 75561
7 EX-101.CAL cyrx-20250331_cal.xml EX-101.CAL 105286
8 EX-101.DEF cyrx-20250331_def.xml EX-101.DEF 317000
9 EX-101.LAB cyrx-20250331_lab.xml EX-101.LAB 693293
10 EX-101.PRE cyrx-20250331_pre.xml EX-101.PRE 546220
105 EXTRACTED XBRL INSTANCE DOCUMENT cyrx-20250331x10q_htm.xml XML 2830636
Mailing Address 112 WESTWOOD PLACE, SUITE 350 BRENTWOOD TN 37027
Business Address 112 WESTWOOD PLACE, SUITE 350 BRENTWOOD TN 37027 (949) 232-1900
Cryoport, Inc. (Filer) CIK: 0001124524 (see all company filings)

EIN.: 880313393 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34632 | Film No.: 25927437
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)